Celldex Therapeutics (Nasdaq: CLDX)
Open: 2.34
Bid: 2.30 x 900
Ask: 2.31 x 700
1y Target Est: 9.00
52wk Range: 2.05 – 4.70
Avg Vol (3m): 235,960
Market Cap: 101.54M
Celldex Therapeutics, Inc. (CLDX) said on Monday a mid-stage trial of its experimental brain cancer vaccine improved survival in patients with ...
Continue Reading →
25
NOV
NOV
0
Share